Abiomed has received FDA pre-market approval for its Impella RP heart pump. Culminating from five years of research, according to a press release, this approval follows the prior FDA hmanitarian device exemption (HDE) received in January 2015 and adds the Impella RP heart pump to Abiomed's platform of PMA-approved devices.